重組SARS-CoV-2 N-NTD(His標(biāo)簽)(＞95%)

特別提示：包括重組SARS-CoV-2 N-NTD(His標(biāo)簽)在內(nèi)，本公司的所有產(chǎn)品僅可用于科研實驗，嚴(yán)禁用于臨床醫(yī)療及其他非科研用途！

產(chǎn)品名稱：重組SARS-CoV-2 N-NTD(His標(biāo)簽)
英文名稱：Recombinant SARS-CoV-2 NP NTD domain(N-His)
產(chǎn)品貨號：JN2090
產(chǎn)品規(guī)格：1mg

本制品由E.coli表達(dá)系統(tǒng)制備，目的基因編碼表達(dá)SARS-CoV-2 Nucleocapsid蛋白NTD域，N端帶有一個6*his標(biāo)簽，用作免疫原或標(biāo)準(zhǔn)品。

技術(shù)指標(biāo)：
Accession#：QHD43423.2
分子量：15.9kDa
實測分子量：16kDa（還原條件下）
純度：＞95%（還原性SDS-PAGE）
純化方式：親和色譜法
貯存液：PBS,2M Urea,pH7.4，0.2μm過濾
保存條件：-20℃。

背景資料：
Coronavirus N protein is required for coronavirus RNA synthesis,and has RNA chaperone activity that may be involved in template switch.Nucleocapsid protein is a most abundant protein of coronavirus.N protein packages the positive strand viral genome RNA into a helical ribonucleocapsid (RNP) and plays a fundamental role during virion assembly through its interactions with the viral genome and membrane protein M.Plays an important role in enhancing the efficiency of subgenomic viral RNA transcription as well as viral replication.Because of the conservation of N protein sequence and its strong immunogenicity,the N protein of coronavirus is chosen as a diagnostic tool.

根據(jù)您的關(guān)注的重組SARS-CoV-2 N-NTD(His標(biāo)簽)(＞95%)，重組新型冠狀病毒NP蛋白NTD域，Recombinant SARS-CoV-2 NP NTD domain(N-His)，重組SARS-CoV-2 NP-NTD，重組SARS-CoV-2 N-NTD，重組新冠病毒NP蛋白NTD域，重組His標(biāo)簽，重組SARS-CoV-2 NP NTD domain(N-His)，重組新冠病毒N蛋白NTD域，重組新冠病毒核衣殼蛋白NTD域，您可能還對以下產(chǎn)品有需求：

 

貨號	名稱	規(guī)格
JN0444	重組人骨保護素(TNFRSF11B)	10μg|50μg|500μg|1mg
JN2025	重組人銅耐受蛋白A(CutA蛋白)	10μg|50μg|500μg|1mg
JN0570	重組人殼三糖酶1(CHIT1)	10μg|50μg|500μg|1mg
JN0641	重組人促腎上腺皮質(zhì)激素釋放因子結(jié)合蛋白(CRHBP)(CRFBP)	10μg|50μg|500μg|1mg
JN0711	重組人N-乙酰-D-氨基葡糖激酶(NAGK)	10μg|50μg|500μg|1mg
JN0740	重組人Protocadherin-1(PCDH1)(原鈣粘蛋白1)	10μg|50μg|500μg|1mg

關(guān)注重組SARS-CoV-2 N-NTD(His標(biāo)簽)(＞95%)，重組新型冠狀病毒NP蛋白NTD域，Recombinant SARS-CoV-2 NP NTD domain(N-His)，重組SARS-CoV-2 NP-NTD，重組SARS-CoV-2 N-NTD，重組新冠病毒NP蛋白NTD域，重組His標(biāo)簽，重組SARS-CoV-2 NP NTD domain(N-His)，重組新冠病毒N蛋白NTD域，重組新冠病毒核衣殼蛋白NTD域的同時，為您推薦更多您可能感興趣的產(chǎn)品：



名稱：重組人VEGF-A(血管內(nèi)皮生長因子A)(帶His標(biāo)簽)
貨號：JN0245
規(guī)格：10μg|50μg|500μg|1mg
本品由我們的哺乳動物表達(dá)系統(tǒng)制備，目的基因編碼的Ala27-Arg147在C端含有His標(biāo)簽。

VEGF121質(zhì)量控制：＞95%(還原性SDS-PAGE)。

VEGF121制劑：凍干品

VEGF121保存：
凍干蛋白可在-20℃長期保存，室溫也可穩(wěn)定保存3周。
復(fù)溶蛋白溶液可在4～7℃保存2～7天。
復(fù)溶后建議分裝凍存在-20℃，可保存3個月，應(yīng)避免反復(fù)凍融。

VEGF121復(fù)溶：
1、試劑開蓋前請先離心。
2、復(fù)溶濃度應(yīng)大于100 μg/ml.
3、凍干蛋白溶于ddH2O中
4、復(fù)溶后根據(jù)使用量分裝保存，避免反復(fù)凍融。

關(guān)于VEGF121：
Human VEGF121, also known as Vascular endothelial growth factor A, VEGFA, Vascular permeability factor, VPF and VEGF, is a homodimeric, heparin-binding glycoprotein which belongs to the platelet-derived growth factor (PDGF)/vascular endothelial growth factor (VEGF) family. VEGF-A is a glycosylated mitogen that specifically acts on endothelial cells and has various effects, including mediating increased vascular permeability, inducing angiogenesis, vasculogenesis, permeabilization of blood vessels and endothelial cell growth, increasing microvascular permeability, promoting cell migration and inhibiting apoptosis. Alternatively spliced transcript variants of VEGF-A encod either secreted or cell-associated isoforms. The lymphangiogenesis may be promoted by upregulation of VEGF121, which may in turn act in part via induction of VEGF-C. It binds to the FLT1/VEGFR1 and KDR/VEGFR2 receptors, heparan sulfate and heparin. NRP1/Neuropilin-1 binds isoforms VEGF-165 and VEGF-145. Isoform VEGF165B binds to KDR but does not activate downstream signaling pathways, does not activate angiogenesis and inhibits tumor growth.